Barclays PLC Decreases Stake in Mettler-Toledo International, Inc. $MTD

Barclays PLC reduced its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 0.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 270,717 shares of the medical instruments supplier’s stock after selling 1,979 shares during the period. Barclays PLC’s holdings in Mettler-Toledo International were worth $377,431,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of MTD. Norges Bank purchased a new position in shares of Mettler-Toledo International in the fourth quarter worth about $520,989,000. M&T Bank Corp raised its stake in Mettler-Toledo International by 2,813.6% during the fourth quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after purchasing an additional 119,942 shares during the period. Capital International Investors raised its stake in Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the period. Alliancebernstein L.P. raised its stake in Mettler-Toledo International by 10.7% during the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after purchasing an additional 76,478 shares during the period. Finally, Northwestern Mutual Wealth Management Co. raised its stake in Mettler-Toledo International by 39,107.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 61,556 shares of the medical instruments supplier’s stock worth $85,821,000 after purchasing an additional 61,399 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,129.89 on Monday. Mettler-Toledo International, Inc. has a 1-year low of $1,023.05 and a 1-year high of $1,525.17. The stock has a market cap of $22.83 billion, a PE ratio of 26.50, a P/E/G ratio of 2.36 and a beta of 1.27. The firm has a 50-day simple moving average of $1,203.88 and a two-hundred day simple moving average of $1,312.61.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business had revenue of $947.13 million during the quarter, compared to analysts’ expectations of $943.14 million. During the same period last year, the business earned $8.19 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, sell-side analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MTD shares. Barclays reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. JPMorgan Chase & Co. reduced their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Finally, Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,408.55.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.